Protalix Biotherapeutics, Inc. (PLX)
2.97
+0.11
(+3.85%)
USD |
NYAM |
Feb 13, 16:00
2.96
-0.01
(-0.34%)
After-Hours: 20:00
Protalix Biotherapeutics Free Cash Flow : -11.69M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Denali Therapeutics, Inc. | -410.85M |
| OraSure Technologies, Inc. | -43.65M |
| Nephros, Inc. | 2.719M |
| Agenus, Inc. | -89.31M |
| Curis, Inc. | -30.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.732M |
| Cash from Investing (Quarterly) | -0.504M |
| Free Cash Flow Per Share (Quarterly) | -0.0523 |
| Free Cash Flow to Equity (Quarterly) | -7.058M |
| Free Cash Flow to Firm (Quarterly) | -4.041M |
| Free Cash Flow Yield | -5.01% |